Published in FEBS Lett on June 06, 1994
LNP 906, the first high-affinity photoaffinity ligand selective for I1 imidazoline receptors. Br J Pharmacol (2004) 0.75
Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proc Natl Acad Sci U S A (1993) 2.95
Nosocomial transmission of hepatitis B virus associated with the use of a spring-loaded finger-stick device. N Engl J Med (1992) 1.85
Amino acids of the Torpedo marmorata acetylcholine receptor alpha subunit labeled by a photoaffinity ligand for the acetylcholine binding site. Biochemistry (1988) 1.80
Double-blind crossover trial of trimethoprim-sulfamethoxazole in spinocerebellar ataxia type 3/Machado-Joseph disease. Arch Neurol (2001) 1.42
Two-photon uncaging: New prospects in neuroscience and cellular biology. Bioorg Med Chem (2010) 1.01
Predominant labeling of beta- over alpha-tubulin from porcine brain by a photoactivatable taxoid derivative. Biochemistry (1994) 1.01
Allosteric transitions of the acetylcholine receptor probed at the amino acid level with a photolabile cholinergic ligand. Proc Natl Acad Sci U S A (1991) 1.00
Photoaffinity labeling of the acetylcholine binding sites on the nicotinic receptor by an aryldiazonium derivative. Biochemistry (1988) 0.99
Interaction of non-competitive blockers within the gamma-aminobutyric acid type A chloride channel using chemically reactive probes as chemical sensors for cysteine mutants. J Biol Chem (1999) 0.97
Dynamic deconvolution of a pre-equilibrated dynamic combinatorial library of acetylcholinesterase inhibitors. Chembiochem (2001) 0.90
Photoaffinity labeling of Torpedo nicotinic receptor with the agonist [3H]DCTA: identification of amino acid residues which contribute to the binding of the ester moiety of acetylcholine. Biochemistry (2000) 0.88
Cysteine mutants as chemical sensors for ligand-receptor interactions. Trends Pharmacol Sci (2001) 0.86
The motor performance test series in Parkinson's disease is influenced by depression. J Neural Transm (Vienna) (1996) 0.85
A mu-opioid receptor-filter assay. Rapid estimation of binding affinity of ligands and reversibility of long-lasting ligand-receptor complexes. Biochem Pharmacol (1988) 0.85
Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry (2001) 0.84
Evaluation of the Short Parkinson's Evaluation Scale: a new friendly scale for the evaluation of Parkinson's disease in clinical drug trials. Clin Neuropharmacol (1997) 0.84
Photoaffinity labelling of cholinesterases. Discrimination between active and peripheral sites. Eur J Biochem (1992) 0.84
[3H](azidophenyl)ureido taxoid photolabels peptide amino acids 281-304 of alpha-tubulin. Biochemistry (1997) 0.83
Cryophotolysis of ortho-nitrobenzyl derivatives of enzyme ligands for the potential kinetic crystallography of macromolecules. Chembiochem (2001) 0.82
Motor performance: normative data, age dependence and handedness. J Neural Transm (Vienna) (2000) 0.81
Disturbance of colour perception in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1993) 0.81
The separation and characterization of sulfate aerosol. Atmos Environ (1975) 0.81
Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF. Biochemistry (1998) 0.79
Affinity labeling of cysteine-mutants evidences contact residues in modeled receptor binding sites. J Recept Signal Transduct Res (2002) 0.79
Fluorescent muscarinic EGFP-hM1 chimeric receptors: design, ligand binding and functional properties. J Recept Signal Transduct Res (1999) 0.79
Functional characterization and potential applications for enhanced green fluorescent protein- and epitope-fused human M1 muscarinic receptors. J Neurochem (1999) 0.79
Cascade cyclization: carbopalladative cyclization followed by electrocyclic closure as a route to complex polycycles. J Am Chem Soc (2001) 0.79
Assessment of symptoms of Parkinson's disease by apparative methods. J Neural Transm Suppl (1987) 0.78
Molecular investigations on the nicotinic acetylcholine receptor: conformational mapping and dynamic exploration using photoaffinity labeling. Mol Neurobiol (1999) 0.78
Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins. J Lipid Mediat (1990) 0.78
Novel photoactivatable agonist of the nicotinic acetylcholine receptor of potential use for exploring the functional activated state. J Neurochem (1996) 0.77
A photoaffinity probe for the polyamine site regulating the NMDA receptor. Eur J Pharmacol (1995) 0.77
Photoactivatable opiate derivatives as irreversible probes of the mu-opioid receptor. J Med Chem (1990) 0.77
Irreversible site-directed labeling of the 4-aminobutyrate binding site by tritiated meta-sulfonate benzene diazonium. Contribution of a nucleophilic amino acid residue of the alpha1 subunit. Eur J Biochem (1999) 0.77
Synthesis of an acetylcholine receptor-specific toxin derivative regioselectively labeled with an undecagold cluster. Bioconjug Chem (1994) 0.76
6-Coumarin diazonium salt: a specific affinity label of the Torpedo acetylcholinesterase peripheral site. Mol Pharmacol (1995) 0.76
2-Diazohistidinyl thyrotropin-releasing hormone (TRH): a photosensitive TRH analog. J Recept Res (1991) 0.76
Trp279 is involved in the binding of quaternary ammonium at the peripheral site of Torpedo marmorata acetylcholinesterase. Eur J Biochem (1994) 0.75
[The use of computers and their limitations in medicine]. Rev Prat (1982) 0.75
A photoactivatable naltrexone derivative labels glycoproteins of different molecular weight corresponding to the mu- and kappa-opioid receptors. Biochemistry (1992) 0.75
Photoaffinity labelling of the mu-opioid receptor is dependent on the nature of the photosensitive group of carfentanil derivatives. Eur J Pharmacol (1990) 0.75
Reactive affinity probes for the mapping of the glycine-binding site of the NMDA receptor NR1 subunit. J Recept Signal Transduct Res (1999) 0.75
Continuous subcutaneous lisuride infusion in OPCA. J Neural Transm Gen Sect (1992) 0.75
Aryldiazonium salts as photoaffinity labels of the nicotinic acetylcholine receptor PCP binding site. FEBS Lett (1985) 0.75
Urethrocavernous fistula: a case report. J Urol (1977) 0.75
Theoretical basis and problems of quantification of movement disorders. Adv Neurol (1999) 0.75
[The little group and its problems]. Rev Prat (1979) 0.75
Pharmacological and structural integrity of muscarinic M2 acetylcholine receptors produced in Sf9 insect cells. Eur J Pharmacol (1997) 0.75
Sustained-release of levodopa: single dose study of a new formulation. J Neural Transm (Vienna) (1996) 0.75
Biochemical evaluation of photolabile precursors of choline and of carbamylcholine for potential time-resolved crystallographic studies on cholinesterases. Biochemistry (1996) 0.75
Nicotinic acetylcholine receptor probed with a photoactivatable agonist: improved labeling specificity by addition of CeIV/glutathione. Extension to laser flash photolabeling. Biochemistry (1999) 0.75
Non peptide photoaffinity probes of the mu-opioid receptor. Prog Clin Biol Res (1990) 0.75
Nicotinic acetylcholine receptor labeled with a tritiated, photoactivatable agonist: a new tool for investigating the functional, activated state. Bioconjug Chem (1997) 0.75
[Birth and development of otorhinolaryngology in the history of medicine]. Acta Otorhinolaryngol Belg (1981) 0.75
Evaluation and biological properties of reactive ligands for the mapping of the glycine site on the N-methyl-D-aspartate (NMDA) receptor. J Med Chem (1999) 0.75
[Continuing medical education in the United States]. Rev Prat (1978) 0.75
Aryl diazo compounds and diazonium salts as potential irreversible probes of the gamma-aminobutyric acid receptor. J Med Chem (1987) 0.75
In vivo binding of [125I]NH2-carfentanil to mu opioid receptors in mouse brain. Nucl Med Biol (1994) 0.75
Photoregulation of cholinesterase activities with caged cholinergic ligands. Methods Enzymol (1998) 0.75
m-Sulfonate benzene diazonium chloride: a powerful affinity label for the gamma-aminobutyric acid binding site from rat brain. J Neurochem (1992) 0.75
[Birth and development of otorhinolaryngology in the history of medicine]. Acta Otorhinolaryngol Belg (1981) 0.75
Covalent labeling of muscarinic acetylcholine receptors by tritiated aryldiazonium photoprobes. Biochem Pharmacol (1997) 0.75
Long-term observation of chronic subcutaneous administration of lisuride in the treatment of motor fluctuations in Parkinson's disease. J Neural Transm Park Dis Dement Sect (1992) 0.75
[F.M.C. and reconversion of the physician at the end of his career]. Rev Prat (1977) 0.75
[Is it necessary to make continuing medical education obligatory?]. Rev Prat (1979) 0.75